Thursday, December 16, 2004

Health Canada approves Alzheimer's drug Ebixa
A new drug to treat Alzheimer's disease has been approved by Health Canada. It doesn't cure the disease, but it can slow down its effects, giving patients more mental clarity.

The drug goes under the generic name memantine, and will be sold under the brand name Ebixa. It was discovered in Germany almost a decade ago and has been used in the United States for the last several years.

No comments: